Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1993)
NovoCure Limited (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
5,607
Price
$13.31
Total Value
$74.60K
Shares Held After
493,793
% of Holdings
1.1%
NovoCure Limited (NVCR)
Puri Michal Nath — Chief Human Resources Officer
Shares
1,100
Price
$13.31
Total Value
$14.64K
Shares Held After
201,322
% of Holdings
0.5%
Orthofix Medical Inc. (OFIX)
McPherron Aviva — Pres, Global Ops & Qual
Shares
1,296
Price
$12.92
Total Value
$16.74K
Shares Held After
69,116
% of Holdings
1.8%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Savage Brian — Interim Chief Legal Officer
Shares
1,186
Price
$32.46
Total Value
$38.50K
Shares Held After
8,461
% of Holdings
12.3%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Savage Brian — Interim Chief Legal Officer
Shares
1,489
Price
$32.46
Total Value
$48.34K
Shares Held After
6,181
% of Holdings
19.4%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
35,710
Price
$19.32
Total Value
$689.83K
Shares Held After
964,161
% of Holdings
3.6%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
14,290
Price
$18.78
Total Value
$268.32K
Shares Held After
999,871
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
57
Price
$325.67
Total Value
$18.56K
Shares Held After
21,227
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
75
Price
$324.88
Total Value
$24.37K
Shares Held After
21,284
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
210
Price
$323.84
Total Value
$68.01K
Shares Held After
21,359
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
96
Price
$323.01
Total Value
$31.01K
Shares Held After
21,569
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
79
Price
$321.82
Total Value
$25.42K
Shares Held After
21,665
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
59
Price
$320.81
Total Value
$18.93K
Shares Held After
21,744
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
28
Price
$320.01
Total Value
$8.96K
Shares Held After
21,803
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
29
Price
$319.03
Total Value
$9.25K
Shares Held After
21,831
% of Holdings
0.1%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
12,000
Price
$9.06
Total Value
$108.72K
Shares Held After
226,581
% of Holdings
5.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
5,614
Price
$89.56
Total Value
$502.79K
Shares Held After
160
% of Holdings
97.2%
TransMedics Group, Inc. (TMDX)
Weill David — Director
Shares
3,571
Price
$146.82
Total Value
$524.29K
Shares Held After
12,134
% of Holdings
22.7%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
131
Price
$6.33
Total Value
$828.58
Shares Held After
296,326
% of Holdings
0.0%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
5,144
Price
$6.23
Total Value
$32.05K
Shares Held After
296,457
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,437
Price
$475.30
Total Value
$1.16M
Shares Held After
15,122
% of Holdings
13.9%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Daniell Richard — EVP, Europe Commercial
Shares
37,372
Price
$32.95
Total Value
$1.23M
Shares Held After
85,755
% of Holdings
30.4%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Daniell Richard — EVP, Europe Commercial
Shares
20,461
Price
$32.46
Total Value
$664.26K
Shares Held After
123,127
% of Holdings
14.2%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Daniell Richard — EVP, Europe Commercial
Shares
33,512
Price
$32.46
Total Value
$1.09M
Shares Held After
123,127
% of Holdings
21.4%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
52
Price
$6.33
Total Value
$328.90
Shares Held After
111,603
% of Holdings
0.0%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
2,032
Price
$6.23
Total Value
$12.66K
Shares Held After
111,655
% of Holdings
1.8%
Orthofix Medical Inc. (OFIX)
REINHARDT MAX — President, Global Spine
Shares
1,080
Price
$12.92
Total Value
$13.95K
Shares Held After
26,401
% of Holdings
3.9%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
26,279
Price
$36.28
Total Value
$953.37K
Shares Held After
357,554
% of Holdings
6.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
19,244
Price
$35.56
Total Value
$684.23K
Shares Held After
383,833
% of Holdings
4.8%
VERACYTE, INC. (VCYT)
Leite John — Chief Commercial Officer-CLIA
Shares
5,260
Price
$35.19
Total Value
$185.08K
Shares Held After
107,580
% of Holdings
4.7%
VERACYTE, INC. (VCYT)
McGuire Annie — SVP, General Counsel
Shares
1,664
Price
$36.34
Total Value
$60.47K
Shares Held After
94,706
% of Holdings
1.7%
VERACYTE, INC. (VCYT)
McGuire Annie — SVP, General Counsel
Shares
4,994
Price
$35.29
Total Value
$176.26K
Shares Held After
96,370
% of Holdings
4.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
223
Price
$325.67
Total Value
$72.62K
Shares Held After
61,805
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
291
Price
$324.88
Total Value
$94.54K
Shares Held After
62,028
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
818
Price
$323.84
Total Value
$264.90K
Shares Held After
62,319
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
374
Price
$323.01
Total Value
$120.81K
Shares Held After
63,137
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
309
Price
$321.82
Total Value
$99.44K
Shares Held After
63,511
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
230
Price
$320.81
Total Value
$73.79K
Shares Held After
63,820
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
109
Price
$320.01
Total Value
$34.88K
Shares Held After
64,050
% of Holdings
0.2%
Orthofix Medical Inc. (OFIX)
Andrews Julie — CFO
Shares
2,425
Price
$12.92
Total Value
$31.32K
Shares Held After
91,109
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
114
Price
$319.03
Total Value
$36.37K
Shares Held After
64,159
% of Holdings
0.2%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
47
Price
$6.29
Total Value
$295.54
Shares Held After
76,226
% of Holdings
0.1%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
1,832
Price
$6.23
Total Value
$11.41K
Shares Held After
76,273
% of Holdings
2.3%
Orthofix Medical Inc. (OFIX)
Calafiore Massimo — Director
Shares
6,189
Price
$12.92
Total Value
$79.94K
Shares Held After
326,167
% of Holdings
1.9%
Warby Parker Inc. (WRBY)
SINGER BRADLEY E — Director
Shares
15,793
Price
$27.53
Total Value
$434.78K
Shares Held After
16,026
% of Holdings
49.6%
Orthofix Medical Inc. (OFIX)
Vitale Lucas — CP&BOO
Shares
1,171
Price
$12.92
Total Value
$15.12K
Shares Held After
165,859
% of Holdings
0.7%
Orthofix Medical Inc. (OFIX)
Fisher Patrick — President, Global Limb Recon
Shares
778
Price
$12.92
Total Value
$10.05K
Shares Held After
51,391
% of Holdings
1.5%
Neuronetics, Inc. (STIM)
MACAN WILLIAM ANDREW — EVP, CLO and CS
Shares
609
Price
$1.34
Total Value
$816.06
Shares Held After
879,525
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
21,097
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
21,305
% of Holdings
1.3%
Showing 1251–1300 of 1993 transactions (page 26 of 40)